speb/financial-data huggingface dataset:
HBIO income_statement (quarterly, 2025-12-31) — Gross Profit: 14172000.00
HBIO income_statement (annual, 2025-12-31) — Impairment Of Capital Assets: 47951000.00
HBIO income_statement (quarterly, 2025-12-31) — Impairment Of Capital Assets: 0.00
HBIO income_statement (annual, 2025-12-31) — Interest Expense: 4917000.00
HBIO income_statement (quarterly, 2025-12-31) — Interest Expense: 2358000.00
HBIO income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 4917000.00
HBIO income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 2358000.00
HBIO cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 3595000.00
HBIO cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 1046000.00
HBIO balance_sheet (annual, 2025-12-31) — Inventory: 20805000.00
HBIO balance_sheet (quarterly, 2025-12-31) — Inventory: 20805000.00
HBIO balance_sheet (annual, 2025-12-31) — Invested Capital: 49604000.00
HBIO balance_sheet (quarterly, 2025-12-31) — Invested Capital: 49604000.00
HBIO cash_flow (annual, 2025-12-31) — Investing Cash Flow: -1863000.00
HBIO cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -599000.00
HBIO cash_flow (annual, 2025-12-31) — Issuance Of Debt: 40000000.00
HBIO cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 40000000.00
HBIO balance_sheet (annual, 2025-12-31) — Leases: 2666000.00
HBIO balance_sheet (quarterly, 2025-12-31) — Leases: 2666000.00
HBIO balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 6882000.00
HBIO balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 6882000.00
HBIO balance_sheet (annual, 2025-12-31) — Long Term Debt: 35870000.00
HBIO balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 35870000.00
HBIO balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 42752000.00
HBIO balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 42752000.00
HBIO cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 40000000.00
HBIO cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 40000000.00
HBIO cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -37350000.00
HBIO cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -34350000.00
HBIO balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 20237000.00
HBIO balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 20237000.00
HBIO balance_sheet (annual, 2025-12-31) — Net Debt: 27256000.00
HBIO balance_sheet (quarterly, 2025-12-31) — Net Debt: 27256000.00
HBIO income_statement (annual, 2025-12-31) — Net Income: -56700000.00
HBIO income_statement (quarterly, 2025-12-31) — Net Income: -2847000.00
HBIO income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -56700000.00
HBIO income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -2847000.00
HBIO income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -56700000.00
HBIO income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -2847000.00
HBIO income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -56700000.00
HBIO income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -2847000.00
HBIO income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -56700000.00
HBIO income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -2847000.00
HBIO cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -56700000.00
HBIO cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -2847000.00
HBIO income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -56700000.00
HBIO income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -2847000.00
HBIO income_statement (annual, 2025-12-31) — Net Interest Income: -4917000.00
HBIO income_statement (quarterly, 2025-12-31) — Net Interest Income: -2358000.00
HBIO cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 0.00
HBIO cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: 0.00
HBIO cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 2650000.00
HBIO cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: 5650000.00
HBIO cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 2650000.00
HBIO cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: 5650000.00
HBIO income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -4917000.00
HBIO income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -2358000.00
HBIO cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -3988000.00
HBIO cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -3202000.00
HBIO balance_sheet (annual, 2025-12-31) — Net PPE: 11959000.00
HBIO balance_sheet (quarterly, 2025-12-31) — Net PPE: 11959000.00
HBIO cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -1258000.00
HBIO cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -449000.00
HBIO balance_sheet (annual, 2025-12-31) — Net Tangible Assets: -3464000.00
HBIO balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: -3464000.00
HBIO balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 317000.00
HBIO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 317000.00
HBIO balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 317000.00
HBIO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 317000.00
HBIO income_statement (annual, 2025-12-31) — Normalized EBITDA: 2156000.00
HBIO income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 721000.00
HBIO income_statement (annual, 2025-12-31) — Normalized Income: -8555480.00
HBIO income_statement (quarterly, 2025-12-31) — Normalized Income: -2654178.84
HBIO cash_flow (annual, 2025-12-31) — Operating Cash Flow: 6729000.00
HBIO cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -96000.00
HBIO cash_flow (annual, 2025-12-31) — Operating Gains Losses: 1363000.00
HBIO income_statement (annual, 2025-12-31) — Operating Income: 100000.00
HBIO income_statement (quarterly, 2025-12-31) — Operating Income: 1927000.00
HBIO income_statement (annual, 2025-12-31) — Operating Revenue: 86550000.00
HBIO income_statement (quarterly, 2025-12-31) — Operating Revenue: 23735000.00
HBIO balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 4471989.00
HBIO balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 4471989.00
HBIO balance_sheet (annual, 2025-12-31) — Other Current Assets: 2763000.00
HBIO balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 2763000.00
HBIO balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 11521000.00
HBIO balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 11521000.00
HBIO balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -11672000.00
HBIO balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -11672000.00
HBIO income_statement (annual, 2025-12-31) — Other Gand A: 17742000.00
HBIO income_statement (quarterly, 2025-12-31) — Other Gand A: 4119000.00
HBIO income_statement (annual, 2025-12-31) — Other Income Expense: -52569000.00
HBIO income_statement (quarterly, 2025-12-31) — Other Income Expense: -2773000.00
HBIO balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 7639000.00
HBIO balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 7639000.00
HBIO cash_flow (annual, 2025-12-31) — Other Non Cash Items: 1322000.00
HBIO cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 624000.00
HBIO balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 2689000.00
HBIO balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 2689000.00
HBIO balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 1308000.00
HBIO balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 1308000.00
HBIO income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: -3889000.00
HBIO income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: -2556000.00
HBIO balance_sheet (annual, 2025-12-31) — Other Properties: 7172000.00
HBIO balance_sheet (quarterly, 2025-12-31) — Other Properties: 7172000.00
HBIO income_statement (annual, 2025-12-31) — Other Special Charges: 541000.00
HBIO income_statement (quarterly, 2025-12-31) — Other Special Charges: 200000.00
HBIO balance_sheet (annual, 2025-12-31) — Payables: 3652000.00
HBIO balance_sheet (quarterly, 2025-12-31) — Payables: 3652000.00
HBIO balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 3652000.00
HBIO balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 3652000.00
HBIO cash_flow (annual, 2025-12-31) — Pension And Employee Benefit Expense: 1233000.00
HBIO cash_flow (quarterly, 2025-12-31) — Pension And Employee Benefit Expense: 1233000.00
HBIO balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 1815000.00
HBIO balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 1815000.00
HBIO balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
HBIO balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
HBIO income_statement (annual, 2025-12-31) — Pretax Income: -57386000.00
HBIO income_statement (quarterly, 2025-12-31) — Pretax Income: -3204000.00
HBIO cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 47000.00
HBIO cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 1000.00
HBIO balance_sheet (annual, 2025-12-31) — Properties: 0.00
HBIO balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
HBIO cash_flow (annual, 2025-12-31) — Purchase Of PPE: -1258000.00
HBIO cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -449000.00
HBIO balance_sheet (annual, 2025-12-31) — Raw Materials: 12172000.00
HBIO balance_sheet (quarterly, 2025-12-31) — Raw Materials: 12172000.00
HBIO balance_sheet (annual, 2025-12-31) — Receivables: 16043000.00
HBIO balance_sheet (quarterly, 2025-12-31) — Receivables: 16043000.00
HBIO income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 34722000.00
HBIO income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 9063000.00
HBIO income_statement (annual, 2025-12-31) — Reconciled Depreciation: 5945000.00
HBIO income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 1350000.00
HBIO cash_flow (annual, 2025-12-31) — Repayment Of Debt: -37350000.00
HBIO cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -34350000.00
HBIO income_statement (annual, 2025-12-31) — Research And Development: 8825000.00
HBIO income_statement (quarterly, 2025-12-31) — Research And Development: 2183000.00
HBIO income_statement (annual, 2025-12-31) — Restructuring And Mergern Acquisition: 188000.00
HBIO income_statement (quarterly, 2025-12-31) — Restructuring And Mergern Acquisition: 17000.00
HBIO balance_sheet (annual, 2025-12-31) — Retained Earnings: -214710000.00
HBIO balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -214710000.00
HBIO cash_flow (annual, 2025-12-31) — Sale Of Investment: 0.00
HBIO cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 0.00
HBIO income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 19216000.00
HBIO income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 5093000.00
HBIO income_statement (annual, 2025-12-31) — Selling General And Administration: 36958000.00
HBIO income_statement (quarterly, 2025-12-31) — Selling General And Administration: 9212000.00
HBIO balance_sheet (annual, 2025-12-31) — Share Issued: 4471989.00
HBIO balance_sheet (quarterly, 2025-12-31) — Share Issued: 4471989.00
HBIO income_statement (annual, 2025-12-31) — Special Income Charges: -48680000.00
HBIO income_statement (quarterly, 2025-12-31) — Special Income Charges: -217000.00
HBIO cash_flow (annual, 2025-12-31) — Stock Based Compensation: 1855000.00
HBIO cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 459000.00
HBIO balance_sheet (annual, 2025-12-31) — Stockholders Equity: 13734000.00
HBIO balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 13734000.00
HBIO balance_sheet (annual, 2025-12-31) — Tangible Book Value: -3464000.00
HBIO balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: -3464000.00
HBIO income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -535480.00
HBIO income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -24178.84
HBIO income_statement (annual, 2025-12-31) — Tax Provision: -686000.00
HBIO income_statement (quarterly, 2025-12-31) — Tax Provision: -357000.00
HBIO income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.01
HBIO income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.11
HBIO balance_sheet (annual, 2025-12-31) — Total Assets: 80071000.00
HBIO balance_sheet (quarterly, 2025-12-31) — Total Assets: 80071000.00
HBIO balance_sheet (annual, 2025-12-31) — Total Capitalization: 49604000.00
HBIO balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 49604000.00
HBIO balance_sheet (annual, 2025-12-31) — Total Debt: 44277000.00
HBIO balance_sheet (quarterly, 2025-12-31) — Total Debt: 44277000.00
HBIO balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 13734000.00
HBIO balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 13734000.00
HBIO income_statement (annual, 2025-12-31) — Total Expenses: 86450000.00
HBIO income_statement (quarterly, 2025-12-31) — Total Expenses: 21808000.00
HBIO balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 66337000.00
HBIO balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 66337000.00
HBIO balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 31846000.00
HBIO balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 31846000.00
HBIO balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 44377000.00
HBIO balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 44377000.00
HBIO income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -48580000.00
HBIO income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 1710000.00
HBIO income_statement (annual, 2025-12-31) — Total Unusual Items: -48680000.00
HBIO income_statement (quarterly, 2025-12-31) — Total Unusual Items: -217000.00
HBIO income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -48680000.00
HBIO income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -217000.00
HBIO balance_sheet (annual, 2025-12-31) — Work In Process: 3262000.00
HBIO balance_sheet (quarterly, 2025-12-31) — Work In Process: 3262000.00
HBIO balance_sheet (annual, 2025-12-31) — Working Capital: 26265000.00
HBIO balance_sheet (quarterly, 2025-12-31) — Working Capital: 26265000.00
HBIO income_statement (quarterly, 2026-03-31) — +Operating Expense: 13183000.00
HBIO income_statement (quarterly, 2026-03-31) — +Total Revenue: 20755000.00
HBIO balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 5287000.00
HBIO balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 14572000.00
HBIO balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 240046000.00
HBIO balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -200000.00
HBIO income_statement (quarterly, 2026-03-31) — Amortization: 820000.00
HBIO cash_flow (quarterly, 2026-03-31) — Amortization Cash Flow: 907000.00
HBIO cash_flow (quarterly, 2026-03-31) — Amortization Of Intangibles: 907000.00
HBIO income_statement (quarterly, 2026-03-31) — Amortization Of Intangibles Income Statement: 820000.00
HBIO cash_flow (quarterly, 2026-03-31) — Asset Impairment Charge: 0.00
HBIO income_statement (quarterly, 2026-03-31) — Basic Average Shares: 4473000.00
HBIO income_statement (quarterly, 2026-03-31) — Basic EPS: -0.77
HBIO cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 8614000.00
HBIO cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -620000.00
HBIO cash_flow (quarterly, 2026-03-31) — Capital Expenditure Reported: -194000.00
HBIO balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 7911000.00
HBIO balance_sheet (quarterly, 2026-03-31) — Capital Stock: 447000.00
HBIO balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 7098000.00
HBIO balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 7098000.00
HBIO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -9000.00
HBIO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -620000.00
HBIO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -662000.00
HBIO cash_flow (quarterly, 2026-03-31) — Change In Account Payable: 1181000.00
HBIO cash_flow (quarterly, 2026-03-31) — Change In Inventory: -1540000.00
HBIO cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: -392000.00
HBIO cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: 139000.00
HBIO cash_flow (quarterly, 2026-03-31) — Change In Payable: 1181000.00
HBIO cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 1181000.00
HBIO cash_flow (quarterly, 2026-03-31) — Change In Receivables: 1406000.00
HBIO cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 794000.00
HBIO cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: 1406000.00
HBIO cash_flow (quarterly, 2026-03-31) — Changes In Cash: -1291000.00
HBIO balance_sheet (quarterly, 2026-03-31) — Common Stock: 447000.00
HBIO balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 10046000.00
HBIO income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 8511000.00
HBIO balance_sheet (quarterly, 2026-03-31) — Current Assets: 47479000.00
HBIO balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 1552000.00
HBIO balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 1552000.00
HBIO balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 3666000.00
HBIO balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 3666000.00
HBIO balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 23863000.00
HBIO cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: -85000.00
HBIO cash_flow (quarterly, 2026-03-31) — Deferred Tax: -85000.00
HBIO cash_flow (quarterly, 2026-03-31) — Depreciation: 443000.00
HBIO cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 1350000.00
HBIO income_statement (quarterly, 2026-03-31) — Depreciation Amortization Depletion Income Statement: 820000.00
HBIO cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 1350000.00
HBIO income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 820000.00
HBIO income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 4473000.00
HBIO income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.77
HBIO income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -3424000.00
HBIO income_statement (quarterly, 2026-03-31) — EBIT: -1579000.00
HBIO income_statement (quarterly, 2026-03-31) — EBITDA: -229000.00
HBIO cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -225000.00
HBIO cash_flow (quarterly, 2026-03-31) — End Cash Position: 7098000.00
HBIO cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -9000.00
HBIO balance_sheet (quarterly, 2026-03-31) — Finished Goods: 5506000.00
HBIO cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -1282000.00
HBIO balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -12313000.00
HBIO income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 4702000.00
HBIO balance_sheet (quarterly, 2026-03-31) — Goodwill: 9372000.00
HBIO balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 16278000.00
HBIO balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 14772000.00
HBIO balance_sheet (quarterly, 2026-03-31) — Gross PPE: 11599000.00
HBIO income_statement (quarterly, 2026-03-31) — Gross Profit: 12244000.00
HBIO income_statement (quarterly, 2026-03-31) — Impairment Of Capital Assets: 0.00
HBIO income_statement (quarterly, 2026-03-31) — Interest Expense: 1728000.00
HBIO income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 1728000.00
HBIO cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 1280000.00
HBIO balance_sheet (quarterly, 2026-03-31) — Inventory: 22205000.00
HBIO balance_sheet (quarterly, 2026-03-31) — Invested Capital: 46257000.00
HBIO cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -620000.00
HBIO balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 6359000.00
HBIO balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 36211000.00
HBIO balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 42570000.00
HBIO balance_sheet (quarterly, 2026-03-31) — Net Debt: 29113000.00
HBIO income_statement (quarterly, 2026-03-31) — Net Income: -3424000.00
HBIO income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -3424000.00
HBIO income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -3424000.00
HBIO income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -3424000.00
HBIO income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -3424000.00
HBIO cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -3424000.00
HBIO income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -3424000.00
HBIO income_statement (quarterly, 2026-03-31) — Net Interest Income: -1728000.00
HBIO cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: 0.00
HBIO income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -1728000.00
HBIO cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -159000.00
HBIO balance_sheet (quarterly, 2026-03-31) — Net PPE: 11599000.00
HBIO cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -426000.00
HBIO cash_flow (quarterly, 2026-03-31) — Net Short Term Debt Issuance: 0.00
HBIO balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: -6232000.00
HBIO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 313000.00
HBIO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 313000.00
HBIO income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 6000.00
HBIO income_statement (quarterly, 2026-03-31) — Normalized Income: -3283000.00
HBIO cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -662000.00
HBIO income_statement (quarterly, 2026-03-31) — Operating Income: -939000.00
HBIO income_statement (quarterly, 2026-03-31) — Operating Revenue: 20755000.00
HBIO balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 4510182.00
HBIO balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 3604000.00
HBIO balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 11183000.00
HBIO balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -12313000.00
HBIO income_statement (quarterly, 2026-03-31) — Other Gand A: 4702000.00
HBIO income_statement (quarterly, 2026-03-31) — Other Income Expense: -640000.00
HBIO balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 6906000.00
HBIO cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 446000.00
HBIO balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 2582000.00
HBIO balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 1146000.00
HBIO income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: -405000.00
HBIO balance_sheet (quarterly, 2026-03-31) — Other Properties: 11599000.00
HBIO balance_sheet (quarterly, 2026-03-31) — Payables: 5287000.00
HBIO balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 5287000.00
HBIO balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 2175000.00
HBIO balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
HBIO income_statement (quarterly, 2026-03-31) — Pretax Income: -3307000.00
HBIO cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 150000.00
HBIO cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -426000.00
HBIO balance_sheet (quarterly, 2026-03-31) — Raw Materials: 13338000.00
HBIO balance_sheet (quarterly, 2026-03-31) — Receivables: 14572000.00
HBIO income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 7981000.00
HBIO income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 1350000.00
HBIO cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: 0.00
HBIO income_statement (quarterly, 2026-03-31) — Research And Development: 2326000.00
HBIO income_statement (quarterly, 2026-03-31) — Restructuring And Mergern Acquisition: 235000.00
HBIO balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -218134000.00
HBIO income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 5335000.00
HBIO income_statement (quarterly, 2026-03-31) — Selling General And Administration: 10037000.00
HBIO balance_sheet (quarterly, 2026-03-31) — Share Issued: 4510182.00
HBIO cash_flow (quarterly, 2026-03-31) — Short Term Debt Payments: 0.00
HBIO income_statement (quarterly, 2026-03-31) — Special Income Charges: -235000.00
HBIO cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 257000.00
HBIO balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 10046000.00
HBIO balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: -6232000.00
HBIO income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -94000.00
HBIO income_statement (quarterly, 2026-03-31) — Tax Provision: 117000.00
HBIO income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
HBIO balance_sheet (quarterly, 2026-03-31) — Total Assets: 77938000.00
HBIO balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 46257000.00
HBIO balance_sheet (quarterly, 2026-03-31) — Total Debt: 44122000.00
HBIO balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 10046000.00
HBIO income_statement (quarterly, 2026-03-31) — Total Expenses: 21694000.00
HBIO balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 67892000.00
HBIO balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 30459000.00
HBIO balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 44029000.00
HBIO income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -1174000.00
HBIO income_statement (quarterly, 2026-03-31) — Total Unusual Items: -235000.00
HBIO income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -235000.00
HBIO balance_sheet (quarterly, 2026-03-31) — Work In Process: 3361000.00
HBIO balance_sheet (quarterly, 2026-03-31) — Working Capital: 23616000.00
HBLENGINE.NS balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -3575539000.00
HBLENGINE.NS balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 2301336000.00
HBLENGINE.NS balance_sheet (annual, 2022-03-31) — Allowance For Doubtful Accounts Receivable: -58947000.00
HBLENGINE.NS income_statement (annual, 2022-03-31) — Amortization: 64548000.00
HBLENGINE.NS balance_sheet (annual, 2022-03-31) — Assets Held For Sale Current: 11520000.00
HBLENGINE.NS balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 1479586000.00
HBLENGINE.NS cash_flow (annual, 2022-03-31) — Cash Dividends Paid: -97018000.00
HBLENGINE.NS balance_sheet (annual, 2022-03-31) — Cash Equivalents: 234333000.00
HBLENGINE.NS balance_sheet (annual, 2022-03-31) — Cash Financial: 262988000.00
HBLENGINE.NS balance_sheet (annual, 2022-03-31) — Current Deferred Taxes Liabilities: 476727000.00
HBLENGINE.NS balance_sheet (annual, 2022-03-31) — Dividends Payable: 5559000.00
HBLENGINE.NS balance_sheet (annual, 2022-03-31) — Finished Goods: 667428000.00
HBLENGINE.NS income_statement (annual, 2022-03-31) — General And Administrative Expense: 300234000.00
HBLENGINE.NS balance_sheet (annual, 2022-03-31) — Gross Accounts Receivable: 2985548000.00
HBLENGINE.NS income_statement (annual, 2022-03-31) — Interest Income: 67135000.00
HBLENGINE.NS income_statement (annual, 2022-03-31) — Interest Income Non Operating: 67135000.00
HBLENGINE.NS cash_flow (annual, 2022-03-31) — Interest Paid Cff: -20849000.00
HBLENGINE.NS balance_sheet (annual, 2022-03-31) — Investments In Other Ventures Under Equity Method: 77023000.00
HBLENGINE.NS balance_sheet (annual, 2022-03-31) — Land And Improvements: 340315000.00
HBLENGINE.NS balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 4191796000.00
HBLENGINE.NS balance_sheet (annual, 2022-03-31) — Net Debt: 4238000.00
HBLENGINE.NS income_statement (annual, 2022-03-31) — Net Income Extraordinary: 0.00
HBLENGINE.NS cash_flow (annual, 2022-03-31) — Net Other Financing Charges: 117867000.00
HBLENGINE.NS cash_flow (annual, 2022-03-31) — Net Other Investing Changes: 74000.00
HBLENGINE.NS balance_sheet (annual, 2022-03-31) — Non Current Deferred Revenue: 0.00
HBLENGINE.NS balance_sheet (annual, 2022-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 19941000.00
HBLENGINE.NS balance_sheet (annual, 2022-03-31) — Non Current Prepaid Assets: 86116000.00
HBLENGINE.NS cash_flow (annual, 2022-03-31) — Other Cash Adjustment Outside Changein Cash: -446436000.00
HBLENGINE.NS balance_sheet (annual, 2022-03-31) — Other Non Current Liabilities: 75000.00
HBLENGINE.NS balance_sheet (annual, 2022-03-31) — Other Payable: 350589000.00
HBLENGINE.NS income_statement (annual, 2022-03-31) — Other Special Charges: -191899000.00
HBLENGINE.NS balance_sheet (annual, 2022-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 126259000.00
HBLENGINE.NS balance_sheet (annual, 2022-03-31) — Prepaid Assets: 301233000.00
HBLENGINE.NS balance_sheet (annual, 2022-03-31) — Properties: 0.00
HBLENGINE.NS balance_sheet (annual, 2022-03-31) — Raw Materials: 1623773000.00
HBLENGINE.NS income_statement (annual, 2022-03-31) — Rent And Landing Fees: 14912000.00
HBLENGINE.NS income_statement (annual, 2022-03-31) — Rent Expense Supplemental: 18500000.00
HBLENGINE.NS balance_sheet (annual, 2022-03-31) — Restricted Cash: 151443000.00
HBLENGINE.NS income_statement (annual, 2022-03-31) — Restructuring And Mergern Acquisition: 694000.00
HBLENGINE.NS balance_sheet (annual, 2022-03-31) — Retained Earnings: 2879401000.00
HBLENGINE.NS cash_flow (annual, 2022-03-31) — Sale Of Business: 74000.00
HBLENGINE.NS income_statement (annual, 2022-03-31) — Selling And Marketing Expense: 480983000.00
HBLENGINE.NS income_statement (annual, 2022-03-31) — Selling General And Administration: 781217000.00
HBLENGINE.NS income_statement (annual, 2022-03-31) — Total Other Finance Cost: 31427000.00
HBLENGINE.NS balance_sheet (annual, 2022-03-31) — Work In Process: 779133000.00
HBLENGINE.NS income_statement (annual, 2022-03-31) — Write Off: 119979000.00
HBLENGINE.NS income_statement (annual, 2023-03-31) — +Operating Expense: 2595229000.00
HBLENGINE.NS income_statement (annual, 2023-03-31) — +Total Revenue: 13576439000.00
HBLENGINE.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 982727000.00
HBLENGINE.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 3120134000.00
HBLENGINE.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -3648666000.00
HBLENGINE.NS balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 2301336000.00
HBLENGINE.NS balance_sheet (annual, 2023-03-31) — Allowance For Doubtful Accounts Receivable: -26399000.00
HBLENGINE.NS income_statement (annual, 2023-03-31) — Amortization: 57105000.00
HBLENGINE.NS cash_flow (annual, 2023-03-31) — Amortization Cash Flow: 57105000.00
HBLENGINE.NS balance_sheet (annual, 2023-03-31) — Assets Held For Sale Current: 0.00
HBLENGINE.NS balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 118864000.00
HBLENGINE.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 277194946.00
HBLENGINE.NS income_statement (annual, 2023-03-31) — Basic EPS: 3.55
HBLENGINE.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: 497322000.00
HBLENGINE.NS balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 1795616000.00
HBLENGINE.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -638834000.00
HBLENGINE.NS balance_sheet (annual, 2023-03-31) — Capital Lease Obligations: 83706000.00
HBLENGINE.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 277195000.00
HBLENGINE.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 1320171000.00
HBLENGINE.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 1332352000.00
HBLENGINE.NS balance_sheet (annual, 2023-03-31) — Cash Equivalents: 663378000.00
HBLENGINE.NS balance_sheet (annual, 2023-03-31) — Cash Financial: 656793000.00
HBLENGINE.NS cash_flow (annual, 2023-03-31) — Change In Inventory: -292144000.00
HBLENGINE.NS cash_flow (annual, 2023-03-31) — Change In Other Current Liabilities: 297819000.00
HBLENGINE.NS cash_flow (annual, 2023-03-31) — Change In Payable: 106839000.00
HBLENGINE.NS cash_flow (annual, 2023-03-31) — Change In Receivables: -247519000.00
HBLENGINE.NS cash_flow (annual, 2023-03-31) — Change In Working Capital: -135005000.00
HBLENGINE.NS cash_flow (annual, 2023-03-31) — Changes In Cash: 631735000.00
HBLENGINE.NS balance_sheet (annual, 2023-03-31) — Common Stock: 277195000.00
HBLENGINE.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: 9514471000.00
HBLENGINE.NS balance_sheet (annual, 2023-03-31) — Construction In Progress: 258701000.00
HBLENGINE.NS income_statement (annual, 2023-03-31) — Cost Of Revenue: 9815566000.00
HBLENGINE.NS balance_sheet (annual, 2023-03-31) — Current Assets: 8715413000.00
HBLENGINE.NS balance_sheet (annual, 2023-03-31) — Current Capital Lease Obligation: 30839000.00
HBLENGINE.NS balance_sheet (annual, 2023-03-31) — Current Debt: 383481000.00
HBLENGINE.NS balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 414320000.00
HBLENGINE.NS balance_sheet (annual, 2023-03-31) — Current Deferred Taxes Liabilities: 0.00
HBLENGINE.NS balance_sheet (annual, 2023-03-31) — Current Liabilities: 2858133000.00
HBLENGINE.NS balance_sheet (annual, 2023-03-31) — Current Provisions: 390431000.00
HBLENGINE.NS cash_flow (annual, 2023-03-31) — Depreciation: 297516000.00
HBLENGINE.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 354621000.00
HBLENGINE.NS income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 354621000.00
HBLENGINE.NS income_statement (annual, 2023-03-31) — Depreciation Income Statement: 297516000.00
HBLENGINE.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 277194946.00
HBLENGINE.NS income_statement (annual, 2023-03-31) — Diluted EPS: 3.55
HBLENGINE.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: 986528000.00
HBLENGINE.NS balance_sheet (annual, 2023-03-31) — Dividends Payable: 5484000.00
HBLENGINE.NS income_statement (annual, 2023-03-31) — EBIT: 1354827000.00
HBLENGINE.NS income_statement (annual, 2023-03-31) — EBITDA: 1709448000.00
HBLENGINE.NS cash_flow (annual, 2023-03-31) — End Cash Position: 1320171000.00
HBLENGINE.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: -95557000.00
HBLENGINE.NS balance_sheet (annual, 2023-03-31) — Finished Goods: 616109000.00
HBLENGINE.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: 585586000.00
HBLENGINE.NS cash_flow (annual, 2023-03-31) — Gain Loss On Investment Securities: -45720000.00
HBLENGINE.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 359912000.00
HBLENGINE.NS balance_sheet (annual, 2023-03-31) — Goodwill: 0.00
HBLENGINE.NS balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 366805000.00
HBLENGINE.NS balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 3146533000.00
HBLENGINE.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 6993505000.00
HBLENGINE.NS income_statement (annual, 2023-03-31) — Gross Profit: 3760873000.00
HBLENGINE.NS income_statement (annual, 2023-03-31) — Interest Expense: 56842000.00
HBLENGINE.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 56842000.00
HBLENGINE.NS income_statement (annual, 2023-03-31) — Interest Income: 56194000.00
HBLENGINE.NS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 56194000.00
HBLENGINE.NS cash_flow (annual, 2023-03-31) — Interest Received Cfi: 55146000.00
HBLENGINE.NS balance_sheet (annual, 2023-03-31) — Inventory: 3362478000.00
HBLENGINE.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 10290974000.00
HBLENGINE.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: -497128000.00
HBLENGINE.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 118864000.00
HBLENGINE.NS balance_sheet (annual, 2023-03-31) — Investments In Other Ventures Under Equity Method: 87073000.00
HBLENGINE.NS balance_sheet (annual, 2023-03-31) — Investmentsin Associatesat Cost: 87073000.00
HBLENGINE.NS cash_flow (annual, 2023-03-31) — Issuance Of Debt: 0.00
HBLENGINE.NS balance_sheet (annual, 2023-03-31) — Land And Improvements: 386107000.00
HBLENGINE.NS balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 52867000.00
HBLENGINE.NS balance_sheet (annual, 2023-03-31) — Long Term Debt: 393022000.00
HBLENGINE.NS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 445889000.00
HBLENGINE.NS cash_flow (annual, 2023-03-31) — Long Term Debt Issuance: 0.00
HBLENGINE.NS cash_flow (annual, 2023-03-31) — Long Term Debt Payments: -177505000.00
HBLENGINE.NS balance_sheet (annual, 2023-03-31) — Long Term Equity Investment: 87073000.00
HBLENGINE.NS balance_sheet (annual, 2023-03-31) — Long Term Provisions: 22491000.00
HBLENGINE.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 4544244000.00
HBLENGINE.NS balance_sheet (annual, 2023-03-31) — Minority Interest: 0.00
HBLENGINE.NS income_statement (annual, 2023-03-31) — Minority Interests: 2074000.00
HBLENGINE.NS cash_flow (annual, 2023-03-31) — Net Business Purchase And Sale: -10000000.00
HBLENGINE.NS income_statement (annual, 2023-03-31) — Net Income: 986528000.00
HBLENGINE.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 986528000.00
HBLENGINE.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 984454000.00
HBLENGINE.NS income_statement (annual, 2023-03-31) — Net Income Extraordinary: 0.00
HBLENGINE.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 986528000.00
HBLENGINE.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 986528000.00
HBLENGINE.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 1286733000.00
HBLENGINE.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 984454000.00
HBLENGINE.NS income_statement (annual, 2023-03-31) — Net Interest Income: -9270000.00
HBLENGINE.NS cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: -274945000.00
HBLENGINE.NS cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: -177505000.00
HBLENGINE.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: -9270000.00
HBLENGINE.NS cash_flow (annual, 2023-03-31) — Net Other Financing Charges: 151205000.00
HBLENGINE.NS cash_flow (annual, 2023-03-31) — Net Other Investing Changes: -74000.00
HBLENGINE.NS balance_sheet (annual, 2023-03-31) — Net PPE: 3344839000.00
HBLENGINE.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -542200000.00
HBLENGINE.NS cash_flow (annual, 2023-03-31) — Net Short Term Debt Issuance: -97440000.00
HBLENGINE.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 9147666000.00
HBLENGINE.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 100846000.00
HBLENGINE.NS balance_sheet (annual, 2023-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 22491000.00
HBLENGINE.NS balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 119872000.00
HBLENGINE.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: 1702018000.00
HBLENGINE.NS income_statement (annual, 2023-03-31) — Normalized Income: 980892732.09
HBLENGINE.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: 1224420000.00
HBLENGINE.NS income_statement (annual, 2023-03-31) — Operating Income: 1165644000.00
HBLENGINE.NS income_statement (annual, 2023-03-31) — Operating Revenue: 13576439000.00
HBLENGINE.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 277194946.00
HBLENGINE.NS cash_flow (annual, 2023-03-31) — Other Cash Adjustment Outside Changein Cash: 191114000.00
HBLENGINE.NS balance_sheet (annual, 2023-03-31) — Other Current Assets: 645847000.00
HBLENGINE.NS balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 467015000.00
HBLENGINE.NS balance_sheet (annual, 2023-03-31) — Other Equity Interest: 5577000.00
HBLENGINE.NS balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 366805000.00
HBLENGINE.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: -21371000.00
HBLENGINE.NS balance_sheet (annual, 2023-03-31) — Other Non Current Assets: -1000.00
HBLENGINE.NS income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 32039000.00
HBLENGINE.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: 309451000.00
HBLENGINE.NS balance_sheet (annual, 2023-03-31) — Other Payable: 435935000.00
HBLENGINE.NS balance_sheet (annual, 2023-03-31) — Other Properties: 8837000.00
HBLENGINE.NS balance_sheet (annual, 2023-03-31) — Other Receivables: 86102000.00
HBLENGINE.NS balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 12181000.00
HBLENGINE.NS income_statement (annual, 2023-03-31) — Other Special Charges: -45720000.00
HBLENGINE.NS income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
HBLENGINE.NS balance_sheet (annual, 2023-03-31) — Payables: 1424146000.00
HBLENGINE.NS balance_sheet (annual, 2023-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 146072000.00
HBLENGINE.NS balance_sheet (annual, 2023-03-31) — Prepaid Assets: 643272000.00
HBLENGINE.NS income_statement (annual, 2023-03-31) — Pretax Income: 1297985000.00
HBLENGINE.NS balance_sheet (annual, 2023-03-31) — Properties: 0.00
HBLENGINE.NS cash_flow (annual, 2023-03-31) — Provisionand Write Offof Assets: 146453000.00
HBLENGINE.NS cash_flow (annual, 2023-03-31) — Purchase Of Business: -10000000.00
HBLENGINE.NS cash_flow (annual, 2023-03-31) — Purchase Of PPE: -638834000.00
HBLENGINE.NS balance_sheet (annual, 2023-03-31) — Raw Materials: 1991033000.00
HBLENGINE.NS income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 9815566000.00
HBLENGINE.NS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 354621000.00
HBLENGINE.NS income_statement (annual, 2023-03-31) — Rent And Landing Fees: 22351000.00
HBLENGINE.NS income_statement (annual, 2023-03-31) — Rent Expense Supplemental: 26765000.00
HBLENGINE.NS cash_flow (annual, 2023-03-31) — Repayment Of Debt: -177505000.00
HBLENGINE.NS balance_sheet (annual, 2023-03-31) — Restricted Cash: 127541000.00
HBLENGINE.NS income_statement (annual, 2023-03-31) — Restructuring And Mergern Acquisition: 0.00
HBLENGINE.NS balance_sheet (annual, 2023-03-31) — Retained Earnings: 3743761000.00
HBLENGINE.NS cash_flow (annual, 2023-03-31) — Sale Of PPE: 96634000.00
HBLENGINE.NS income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 555439000.00
HBLENGINE.NS income_statement (annual, 2023-03-31) — Selling General And Administration: 915351000.00
HBLENGINE.NS balance_sheet (annual, 2023-03-31) — Share Issued: 277194946.00
HBLENGINE.NS income_statement (annual, 2023-03-31) — Special Income Charges: 7430000.00
HBLENGINE.NS balance_sheet (annual, 2023-03-31) — Stockholders Equity: 9514471000.00
HBLENGINE.NS balance_sheet (annual, 2023-03-31) — Tangible Book Value: 9147666000.00
HBLENGINE.NS income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: 1794732.09
HBLENGINE.NS income_statement (annual, 2023-03-31) — Tax Provision: 313531000.00
HBLENGINE.NS income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.24
HBLENGINE.NS balance_sheet (annual, 2023-03-31) — Taxes Receivable: 43534000.00
HBLENGINE.NS cash_flow (annual, 2023-03-31) — Taxes Refund Paid: -367238000.00
HBLENGINE.NS balance_sheet (annual, 2023-03-31) — Total Assets: 12941830000.00
HBLENGINE.NS balance_sheet (annual, 2023-03-31) — Total Capitalization: 9907493000.00
HBLENGINE.NS balance_sheet (annual, 2023-03-31) — Total Debt: 860209000.00
HBLENGINE.NS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 9514471000.00
HBLENGINE.NS income_statement (annual, 2023-03-31) — Total Expenses: 12410795000.00
HBLENGINE.NS balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 3427359000.00
HBLENGINE.NS balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 4226417000.00
HBLENGINE.NS balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 569226000.00
HBLENGINE.NS income_statement (annual, 2023-03-31) — Total Other Finance Cost: 8622000.00
HBLENGINE.NS balance_sheet (annual, 2023-03-31) — Total Tax Payable: 0.00
HBLENGINE.NS income_statement (annual, 2023-03-31) — Total Unusual Items: 7430000.00
HBLENGINE.NS income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: 7430000.00
HBLENGINE.NS balance_sheet (annual, 2023-03-31) — Work In Process: 755336000.00
HBLENGINE.NS balance_sheet (annual, 2023-03-31) — Working Capital: 5857280000.00
HBLENGINE.NS income_statement (annual, 2023-03-31) — Write Off: 38290000.00
HBLENGINE.NS income_statement (annual, 2024-03-31) — +Operating Expense: 3528880000.00
HBLENGINE.NS income_statement (annual, 2024-03-31) — +Total Revenue: 22214540000.00
HBLENGINE.NS balance_sheet (annual, 2024-03-31) — Accounts Payable: 1304919000.00
HBLENGINE.NS balance_sheet (annual, 2024-03-31) — Accounts Receivable: 3523314000.00
HBLENGINE.NS balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -3856709000.00
HBLENGINE.NS balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 2301336000.00
HBLENGINE.NS balance_sheet (annual, 2024-03-31) — Allowance For Doubtful Accounts Receivable: -106500000.00
HBLENGINE.NS income_statement (annual, 2024-03-31) — Amortization: 60485000.00
HBLENGINE.NS cash_flow (annual, 2024-03-31) — Amortization Cash Flow: 60485000.00
HBLENGINE.NS balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 100867000.00
HBLENGINE.NS income_statement (annual, 2024-03-31) — Basic Average Shares: 277194946.00
HBLENGINE.NS income_statement (annual, 2024-03-31) — Basic EPS: 10.13
HBLENGINE.NS cash_flow (annual, 2024-03-31) — Beginning Cash Position: 1320171000.00
HBLENGINE.NS balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 1894181000.00
HBLENGINE.NS cash_flow (annual, 2024-03-31) — Capital Expenditure: -741075000.00
HBLENGINE.NS balance_sheet (annual, 2024-03-31) — Capital Lease Obligations: 81385000.00
HBLENGINE.NS balance_sheet (annual, 2024-03-31) — Capital Stock: 277195000.00
HBLENGINE.NS balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 2234683000.00
HBLENGINE.NS balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 2289241000.00
HBLENGINE.NS balance_sheet (annual, 2024-03-31) — Cash Equivalents: 1790277000.00
HBLENGINE.NS balance_sheet (annual, 2024-03-31) — Cash Financial: 444406000.00
HBLENGINE.NS cash_flow (annual, 2024-03-31) — Change In Inventory: -964710000.00
HBLENGINE.NS cash_flow (annual, 2024-03-31) — Change In Other Current Assets: -11729000.00
HBLENGINE.NS cash_flow (annual, 2024-03-31) — Change In Other Current Liabilities: 436264000.00
HBLENGINE.NS cash_flow (annual, 2024-03-31) — Change In Payable: 322192000.00
HBLENGINE.NS cash_flow (annual, 2024-03-31) — Change In Receivables: -796665000.00
HBLENGINE.NS cash_flow (annual, 2024-03-31) — Change In Working Capital: -1014648000.00
HBLENGINE.NS cash_flow (annual, 2024-03-31) — Changes In Cash: 1759949000.00
HBLENGINE.NS balance_sheet (annual, 2024-03-31) — Common Stock: 277195000.00